Company News, Patents

Dow Patents Topical Acne Medication

Patent No. US 7,326,408 B2:
A method for increasing the compliance in the use of topical sunscreens comprising a photostable, chemically stable and physically stable formulation for topical application to the skin for treating acne vulgaris and protecting skin from the harmful effects of chronic exposure to the sun comprising a vehicle, one or more sunscreen agents dissolved or suspended in the vehicle, which sunscreen agent is selected from the group consisting of titanium dioxide, zinc oxide, bisoctrizole, anisotriazine, para-aminobenzoic acid (PABA) and derivatives has been assigned to Dow Pharmaceutical Sciences, Petaluma, CA.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters